BSECompany Update6d ago · 14 Aug 2026, 05:19 pm

Disclosure under Regulation 30 (SEBI LODR) Outcome of Board Meeting

Rubicon Research Ltd · 544578

✦ AI SummaryMgmt Change

Rubicon Research Ltd announced the appointment of Mr. Rohit Saraogi as Chief Financial Officer (CFO) and the re-appointment and extension of the term of Mr. Venkat Changavalli as the Chairman of the Company. The Board of Directors approved the appointments at its meeting held on August 14, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment7/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Rubicon Research Ltd - 544578 - Announcement under Regulation 30 (LODR)-Change in Management

Attachments (1)

📄

0ed42b8b-a41b-4be6-a3a7-ae3aa0f7a140.pdf

pdf

Download →
View document text
Date: August 14, 2026 To, To, BSE Limited National Stock Exchange of India Limited Listing Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, 5th floor, Plot no. C/1, G Block Dalal Street – Fort Bandra Kurla Complex, Bandra (East), Mumbai 400 001 Mumbai - 400 051 Scrip Code: 544578 NSE Symbol: RUBICON ISIN: INE506V01022 Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) – Outcome of the Board Meeting. Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform that the Board of Directors of the Company at its meeting held today i.e., on August 14, 2026, has inter alia, considered and approved the following: 1. Appointment of Senior Management Personnel and CFO Leadership Transition Appointment of Mr. Rohit Saraogi, Chief Financial Officer (“CFO”) - Designate, as a Senior Management Personnel of the Company, effective August 14, 2026. Mr. Nitin Jajodia, the current CFO and Key Managerial Personnel (“KMP”) of the Company, will, upon recommendation of the Nomination and Remuneration Committee and the Audit Committee, move to an operating/business role as Chief Commercial Officer (“CCO”). Concurrently, Mr. Rohit Saraogi will assume charge as CFO and KMP of the Company, subject to receipt of such other approvals as may be necessary. This appointment and the related transition are a significant step as the Company prepares for its new phase of growth in the coming years. Note: The approval of the Board of Directors will be separately obtained in respect of the effective date of the change in KMP, subject to such other approvals as may be required. Rubicon Research Limited (formerly known as Rubicon Research Private Limited) | CIN: L73100MH1999PLC119744 Registered Office: Plot No. B-75, MedOne House, Road No. 33, Wagle Estate, Thane West, PIN – 400 604, Maharashtra, India +91-22-61414000 / 50414000 | reachus@rubicon.co.in | www.rubicon.co.in 2. Re-appointment and Extension of Tenure of the Chairman Re-appointment and extension of the term of Mr. Venkat Changavalli as the Chairman of the Company, effective from September 18, 2026, to June 10, 2027 (co-terminus with the completion of his first term as an Independent Director). Details as required under SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026, are enclosed as Annexure – A. The Meeting of the Board of Directors of the Company commenced at 03:00 PM (IST) and concluded at 04:15 PM (IST). Kindly take the above information on record. Thanking you, Yours faithfully, For Rubicon Research Limited Deepashree Tanksale Company Secretary M. No. A28132 Encl.: As above Rubicon Research Limited (formerly known as Rubicon Research Private Limited) | CIN: L73100MH1999PLC119744 Registered Office: Plot No. B-75, MedOne House, Road No. 33, Wagle Estate, Thane West, PIN – 400 604, Maharashtra, India +91-22-61414000 / 50414000 | reachus@rubicon.co.in | www.rubicon.co.in Annexure – A S. No. Particulars Mr. Rohit Saraogi Mr. Venkat Changavalli 1. Reason for change viz. Appointment of Mr. Rohit Saraogi, Re-appointment and extension of the appointment, Chief Financial Officer (“CFO”) - term of Mr. Venkat Changavalli as the resignation, removal, Designate, as a Senior Management Chairman of the Company, effective death or otherwise Personnel of the Company, from September 18, 2026, to June 10, 2. Date of appointment/ effective August 14, 2026. 2027 (co-terminus with the resignation & term of Term of Appointment: As per completion of his first term as an appointment. Policy of the Company Independent Director). 3. Brief profile (in case of Mr. Rohit Saraogi is a passionate Mr. Venkat Changavalli serves as the appointment) financial professional with over 24 Chairman and Independent Director years of experience spanning on the Board of the Company. He leading multinational corporations holds a bachelor’s degree in and Indian promoter led technology from Jawaharlal Nehru enterprises, including Vini Technological University, Andhra Cosmetics, S H Kelkar & Co, Bajaj Pradesh (1976), and a Post Graduate Consumer Care, Diageo, Marico, Diploma in Management from the Reckitt Benckiser, and Coca Cola. A Indian Institute of Management qualified Chartered Accountant and (IIM), Ahmedabad (1977). Company Secretary, he brings Mr. Changavalli brings industry expertise across commercial and expertise and professional business finance, cross border experience in the pharmaceutical M&A, capital allocation, global sector. treasury, investor relations, and large-scale digital finance Detailed profile is available at the transformations in both FMCG/B2C website of the Company at and B2B sectors. www.rubicon.co.in. 4. Disclosure of Not Applicable None relationships between directors (in case of appointment of a director) 5 Information as Not Applicable Mr. Venkat Changavalli is not required pursuant to debarred from continuing the office Rubicon Research Limited (formerly known as Rubicon Research Private Limited) | CIN: L73100MH1999PLC119744 Registered Office: Plot No. B-75, MedOne House, Road No. 33, Wagle Estate, Thane West, PIN – 400 604, Maharashtra, India +91-22-61414000 / 50414000 | reachus@rubicon.co.in | www.rubicon.co.in BSE circular with ref. of Chairman and Independent no. LIST/ COMP/ 14/ Director by virtue of any SEBI order or 2018- 19 dated June any other such authority. 20, 2018, and the NSE circular ref. no. NSE/ CML/ 2018/24 dated June 20, 2018. For Rubicon Research Limited Deepashree Tanksale Company Secretary M. No. A28132 Encl.: As above Rubicon Research Limited (formerly known as Rubicon Research Private Limited) | CIN: L73100MH1999PLC119744 Registered Office: Plot No. B-75, MedOne House, Road No. 33, Wagle Estate, Thane West, PIN – 400 604, Maharashtra, India +91-22-61414000 / 50414000 | reachus@rubicon.co.in | www.rubicon.co.in